Found: 25
Select item for more details and to access through your institution.
Development of Dual Inhibitors against Alzheimer's Disease Using Fragment-Based QSAR and Molecular Docking.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Novel Natural Structure Corrector of ApoE4 for Checking Alzheimer's Disease: Benefits from High Throughput Screening and Molecular Dynamics Simulations.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Novel Natural Structure Corrector of ApoE4 for Checking Alzheimer's Disease: Benefits from High Throughput Screening and Molecular Dynamics Simulations.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/620793
- By:
- Publication type:
- Article
Cell Transdifferentiation and Reprogramming in Disease Modeling: Insights into the Neuronal and Cardiac Disease Models and Current Translational Strategies.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2558, doi. 10.3390/cells10102558
- By:
- Publication type:
- Article
A theoretical investigation of DNA dynamics and desolvation kinetics for zinc finger proteinZif268.
- Published in:
- BMC Genomics, 2015, v. 16, p. 1, doi. 10.1186/1471-2164-16-S12-S5
- By:
- Publication type:
- Article
Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.
- Published in:
- BMC Genomics, 2015, v. 16, p. 1, doi. 10.1186/1471-2164-16-S2-S14
- By:
- Publication type:
- Article
Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the a-b interfacial site of human tubulin.
- Published in:
- BMC Genomics, 2014, v. 15, p. 1, doi. 10.1186/1471-2164-15-S9-S3
- By:
- Publication type:
- Article
Structural insights into mode of actions of novel natural Mycobacterium protein tyrosine phosphatase B inhibitors.
- Published in:
- BMC Genomics, 2014, v. 15, p. 1, doi. 10.1186/1471-2164-15-S1-S3
- By:
- Publication type:
- Article
Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.
- Published in:
- BMC Genomics, 2013, v. 14, p. 1, doi. 10.1186/1471-2164-14-S8-S10
- By:
- Publication type:
- Article
Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5463, doi. 10.3390/ijms21155463
- By:
- Publication type:
- Article
Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus.
- Published in:
- BMC Bioinformatics, 2014, v. 15, n. Suppl 16, p. 1, doi. 10.1186/1471-2105-15-S16-S13
- By:
- Publication type:
- Article
Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0356-0
- By:
- Publication type:
- Article
Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and Mortaparib<sup>Plus</sup>.
- Published in:
- Bioscience Reports, 2021, v. 41, n. 10, p. 1, doi. 10.1042/BSR20212156
- By:
- Publication type:
- Article
Editorial: Genomic alteration landscapes of aging, metabolic disorders, and cancer: Emerging overlaps and clinical importance.
- Published in:
- Frontiers in Genetics, 2023, v. 13, p. 1, doi. 10.3389/fgene.2022.1102953
- By:
- Publication type:
- Article
COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.662786
- By:
- Publication type:
- Article
Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Mutant p53 L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to Mortaparib Plus , a Multimodal Small Molecule Inhibitor.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3043, doi. 10.3390/cancers13123043
- By:
- Publication type:
- Article
Identification and Characterization of Mortaparib Plus —A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 835, doi. 10.3390/cancers13040835
- By:
- Publication type:
- Article
Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1160, doi. 10.3390/cancers12051160
- By:
- Publication type:
- Article
Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-775
- By:
- Publication type:
- Article
Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. 1, doi. 10.1186/s13046-019-1500-9
- By:
- Publication type:
- Article
Wild type p53 function in p53<sup>Y220C</sup> mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1099-x
- By:
- Publication type:
- Article
Mixed Inhibition of cPEPCK by Genistein, Using an Extended Binding Site Located Adjacent to Its Catalytic Cleft.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141987
- By:
- Publication type:
- Article
Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134691
- By:
- Publication type:
- Article
Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence.
- Published in:
- Marine Drugs, 2019, v. 17, n. 6, p. 338, doi. 10.3390/md17060338
- By:
- Publication type:
- Article